Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Rationale and Design of a Phase 3 Study to Evaluate the Efficacy and Safety of ION-682884 in Patients with Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)

Rodney H Falk, MD, Morie A Gertz, MD, Merrill D Benson, MD, Gustavo Buchele, MD PhD, Michela Brambatti, MD MS, Sotirios Tsimikas, MD, Nicholas J Viney, Bsc, Li-Jung Tai, MD PhD, Cecilia Monteiro, MD PhD, Qingqing Yang, MS, Louis St L O'Dea, MB B.Ch. BAO, FRCP, Ewa Karwatowska-Prokopczuk, MD PhD, Eugene Schneider, MD, Richard S Geary, PhD, Brett P Monia, PhD

Blood (2019) 134 (Supplement_1): 5764.

https://doi.org/10.1182/blood-2019-129269

Published: 2019

Journal Articles

Developing a Galnac-Conjugated TMPRSS6 Antisense Therapy for the Treatment of β-Thalassemia

Mariam Aghajan, PhD, Carla Casu, PhD, Vania lo Presti, Sheri Booten, Brett P. Monia, PhD, Stefano Rivella, PhD, Shuling Guo, PhD

Blood (2016) 128 (22): 1013.

https://doi.org/10.1182/blood.V128.22.1013.1013

Published: 2016

Journal Articles

Anti-CD38 Pretargeted Radioimmunotherapy Eradicates Multiple Myeloma Xenografts In a Murine Model

Damian J. Green, MD, Jon C. Jones, Mark D. Hylarides, PhD, Donald K. Hamlin, BS, D Scott Wilbur, PhD, Yukang Lin, PhD, Aimee L. Kenoyer, BS, Shani L. Frayo, BS, William I. Bensinger, MD, Ajay K. Gopal, MD, Johnnie J. Orozco, MD, PhD, Theodore A. Gooley, PhD, Brent L. Wood, MD, PhD, John M. Pagel, MD, PhD, Oliver W. Press, MD, PhD

Blood (2013) 122 (21): 882.

https://doi.org/10.1182/blood.V122.21.882.882

Published: 2013

Journal Articles

Anti-CD38 Pretargeted Radioimmunotherapy Demonstrates Therapeutic Efficacy In a Human Multiple Myeloma Mouse Xenograft Model

Damian J. Green, MD, Nural N. Orgun, Mark D. Hylarides, PhD, John M. Pagel, MD, PhD, Donald K. Hamlin, D. Scott Wilbur, PhD, Yukang Lin, PhD, Amiee L. Kenoyer, Shani L. Frayo, BS, William I. Bensinger, MD, Ajay K. Gopal, MD, Johnnie J. Orozco, MD, PhD, Theodore A. Gooley, PhD, Brent L. Wood, MD, PhD, Oliver W. Press, MD, PhD

Blood (2011) 118 (21): 1842.

https://doi.org/10.1182/blood.V118.21.1842.1842

Published: 2011

Journal Articles

Conventional and Pretargeted Radioimmunotherapy with Bismuth-213 to Target and Treat CD20-Expressing Non-Hodgkin Lymphoma: A Preclinical Model for Consolidation Therapy to Eradicate Minimal Residual Disease.

Steven I. Park, MD, Jaideep Shenoi, MD, John M. Pagel, MD, PhD, Donald K. Hamlin, Nural Orgun, Aimee L. Kenoyer, Shani M. Wilbur, BS, Amanda Axtman, D. Scott Wilbur, PhD, Yukang Lin, PhD, Darrell R. Fisher, PhD, Ajay K. Gopal, MD, Damian J. Green, MD, Oliver W. Press, MD, PhD

Blood (2009) 114 (22): 2705.

https://doi.org/10.1182/blood.V114.22.2705.2705

Published: 2009

Journal Articles

Anti-CD45 Pretargeted Radioimmunotherapy in a Nonhuman Primate Model.

Damian J. Green, MD, John M. Pagel, MD, PhD, Eneida R. Nemecek, MD, Anastasia Pantelias, MA, Yukang Lin, PhD, Aimee L. Kenoyer, Darrell R. Fisher, PhD, D.S. Wilbur, PhD, Donald K. Hamlin, Ajay K. Gopal, MD, Oliver W. Press, MD, PhD

Blood (2007) 110 (11): 2336.

https://doi.org/10.1182/blood.V110.11.2336.2336

Published: 2007

Journal Articles

The DC-SIGN–related lectin LSECtin mediates antigen capture and pathogen binding by human myeloid cells

Angeles Dominguez-Soto, Laura Aragoneses-Fenoll, Enrique Martin-Gayo, Lorena Martinez-Prats, Maria Colmenares, Marisa Naranjo-Gomez, Francesc E. Borras, Pilar Munoz, Mercedes Zubiaur, Maria L. Toribio, Rafael Delgado, Angel L. Corbi

Blood (2007) 109 (12): 5337–5345.

https://doi.org/10.1182/blood-2006-09-048058

Published: 2007

Journal Articles

Comparative biodistributions of pretargeted radioimmunoconjugates targeting CD20, CD22, and DR molecules on human B-cell lymphomas

Anastasia Pantelias, John M. Pagel, Nathan Hedin, Laura Saganic, Shani Wilbur, Donald K. Hamlin, D. Scott Wilbur, Yukang Lin, Diane Stone, Don Axworthy, Ajay K. Gopal, Oliver W. Press

Blood (2007) 109 (11): 4980–4987.

https://doi.org/10.1182/blood-2006-11-056895

Published: 2007

Journal Articles

Conventional and Pretargeted Radioimmunotherapy Using an Anti-Murine CD45 Monoclonal Antibody in a Syngeneic, Disseminated Murine Leukemia Model.

John M. Pagel, MD,PhD, Nathan Hedin, Lacey Drouet, Anastasia Pantelias, Yukang Lin, PhD, Don Hamlin, Darrell Fisher, PhD, D. Scott Wilbur, MD, Ajay K. Gopal, MD, Damian Green, MD, Frederick R. Appelbaum, MD, Oliver W. Press, MD,PhD

Blood (2006) 108 (11): 570.

https://doi.org/10.1182/blood.V108.11.570.570

Published: 2006

Journal Articles

Intracellular Trafficking of Factor V Subsequent to Its Endocytosis by Megakaryocytes.

Lorna W. Seifert, Alexa Wahle-Ritchie, Beth A. Bouchard, PhD, Paula B. Tracy, PhD

Blood (2005) 106 (11): 1031.

https://doi.org/10.1182/blood.V106.11.1031.1031

Published: 2005

Journal Articles

Comparison of Biodistributions and Therapeutic Efficacies of Pretargeted Radioimmunoconjugates Targeting the CD20, CD22, and DR Molecules on Human B Cell Lymphomas.

Anastasia Pantelias, John M. Pagel, Nathan Hedin, Yukang Lin, Donald Axworthy, Louis J. Theodore, Oliver W. Press

Blood (2005) 106 (11): 611.

https://doi.org/10.1182/blood.V106.11.611.611

Published: 2005

Journal Articles

Protective effect of granulocyte colony-stimulating factor against T- cell-meditated lethal shock triggered by superantigens

Y Aoki, K Hiromatsu, N Kobayashi, T Hotta, H Saito, H Igarashi, Y Niho, Y Yoshikai

Blood (1995) 86 (4): 1420–1427.

https://doi.org/10.1182/blood.V86.4.1420.bloodjournal8641420

Published: 1995

NARROW

Rationale and Design of a Phase 3 Study to Evaluate the Efficacy and Safety of ION-682884 in Patients with Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)

Developing a Galnac-Conjugated TMPRSS6 Antisense Therapy for the Treatment of β-Thalassemia

Anti-CD38 Pretargeted Radioimmunotherapy Eradicates Multiple Myeloma Xenografts In a Murine Model

Anti-CD38 Pretargeted Radioimmunotherapy Demonstrates Therapeutic Efficacy In a Human Multiple Myeloma Mouse Xenograft Model

Conventional and Pretargeted Radioimmunotherapy with Bismuth-213 to Target and Treat CD20-Expressing Non-Hodgkin Lymphoma: A Preclinical Model for Consolidation Therapy to Eradicate Minimal Residual Disease.

Anti-CD45 Pretargeted Radioimmunotherapy in a Nonhuman Primate Model.

The DC-SIGN–related lectin LSECtin mediates antigen capture and pathogen binding by human myeloid cells

Comparative biodistributions of pretargeted radioimmunoconjugates targeting CD20, CD22, and DR molecules on human B-cell lymphomas

Conventional and Pretargeted Radioimmunotherapy Using an Anti-Murine CD45 Monoclonal Antibody in a Syngeneic, Disseminated Murine Leukemia Model.

Intracellular Trafficking of Factor V Subsequent to Its Endocytosis by Megakaryocytes.

Comparison of Biodistributions and Therapeutic Efficacies of Pretargeted Radioimmunoconjugates Targeting the CD20, CD22, and DR Molecules on Human B Cell Lymphomas.

Protective effect of granulocyte colony-stimulating factor against T- cell-meditated lethal shock triggered by superantigens

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only